Tumor necrosis factor-alpha G308α gene polymorphism and essential hypertension: A meta-analysis involving 2244 Participants

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Li, Yan Yan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; RECESSIVE INHERITANCE; STATISTICAL ANALYSIS; TNF ALPHA GENE; AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; META ANALYSIS; RISK;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859873171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035408     Document Type: Article

References (26)

1. Won JH, Ehret G, Chakravarti A, Olshen RA, (2011) SNPs and other features as they predispose to complex disease: genome-wide predictive analysis of a quantitative phenotype for hypertension. PLoS One 6: e27891.
2. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP, (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53: 577-584.
3. Kahaleh MB, Fan PS, (1997) Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 15: 163-167.
4. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ, (2000) Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 1: 386-390.
5. Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, et al. (2005) The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens 18: 1271-1275.
6. Liu ZW, Li JC, Li MX, Chen SQ, (2009) Study on TNFα-238G/A polymorphisnis in patients with cerebral infarction. Anat Res, 31: 259-262.
7. Li CQ, Wang F, Wang YG, (2010) The Association of the TNF-α Gene of G-308A Genotypes in Chinese hyperuricemia patients and cardiovascular risk factors. Molecular Cardiology of China 10: 29-32.
8. Bogdański P, Kujawska-Łuczak M, Łacki J, Pupek-Musialik D, (2003) Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension. Pol Merkur Lekarski15:347-349; discussion 349-51.
9. Mazor R, Itzhaki O, Sela S, Yagil Y, Cohen-Mazor M, et al. (2010) Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension 55: 353-362.
10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199.
11. Sheu WH, Lee WJ, Lin LY, Chang RL, Chen YT, (2001) Tumor necrosis factor alpha -238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism 50: 1447-1451.
12. Li H, (2003) Clinical and Basic Research on Essential Hypertensives with Insulin Resistance. Shanghai Shanghai Second Medical University Press.
13. Wu XB, Zhou SH, (2004) Association of the tumor necrosis factor-alpha gene G308A promoter polymorphism with essential hypertension. Chin J Hyper 12: 415-418.
14. Yoo CS, Hwang WJ, Hong SH, Lee HJ, Jeong HJ, et al. (2007) Relationship between iris constitution analysis and TNF-alpha gene polymorphism in hypertensives. Am J Chin Med 35: 621-629.
15. Guo LW, Wu HY, Huang YM, Li R, Wang KJ, et al. (2009) Correlation between tumor necrosis factor α and β gene polymorphisms and essential hypertension. Journal of Xinxiang Medical College 26: 352-354.
16. Peng CY, Zhou CL, He QZ, (2011) Association of TNF-α gene -308G/A polymorphism with essential hypertension in Han racial origin in Hunan. Chin J Clin Pharmacol Ther 16: 57-60.
17. Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, et al. (2005) The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens 18: 1271-1275.
18. Cochran WG, (1968) The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24: 295-313.
19. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
20. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
21. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315: 629-634.
22. Amer MS, Elawam AE, Khater MS, Omar OH, Mabrouk RA, et al. (2011) Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults. J Am Soc Hypertens 5: 395-400.
23. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, et al. (2005) Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum Mol Genet 14: 1805-1814.
24. Martens FM, Rabelink TJ, op 't Roodt J, de Koning EJ, Visseren FL, (2006) TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J 27: 1605-1609.
25. Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, et al. (2001) Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol 28: 188-192.
26. Krikovszky D, Vásárhelyi B, Tóth-Heyn P, Körner A, Tulassay T, et al. (2002) Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents. Clin Genet 62: 474-477.